Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06679790 · ClinicalTrials.gov registry record · NA

Trajectories of Change in Tourette Syndrome

A NA study of Tourette Syndrome and Tic Disorders, sponsored by University of Minnesota.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06679790: Recruiting NA study of Tourette Syndrome and Tic Disorders, sponsored by University of Minnesota.

NCT06679790 is a NA study of Tourette Syndrome and Tic Disorders that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 30 participants, below the 86-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06679790, a NA study of Tourette Syndrome and Tic Disorders, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This K23 Career Development Award is designed to provide the training needed for the PI to achieve her long-term career goal of conducting independent, programmatic intervention research in developmental populations. The training will emphasize gaining expertise in higher-intensity, multi-method, within-subject data collection and analysis. This award builds on the PI's emerging experience in tic disorders and pediatric behavioral interventions, and her ability to quickly learn and apply advanced statistical methods. The award will extend the PI's training through the following short-term training goals: 1) multi-method data collection and integration (electronic momentary assessment \[EMA\], wearable devices, neurocognitive tasks), 2) leading and designing pediatric clinical trials, 3) managing and analyzing large, multilevel datasets, and 4) career development and contribution to the field. The PI has developed a training plan to accomplish these goals in concert with her mentors, a team of leading experts in the fields of psychiatry and psychology, who will closely monitor training through regular meetings. The highly structured training plan also includes a set of formal coursework and workshops for each training goal to complement the hands-on experience the PI will gain from leading the research project. The objective of this proposal is to comprehensively map symptom change across time and during a behavioral intervention for youth with Persistent Tic Disorders (PTDs). PTDs affect approximately 1% of the population, can cause significant disability, have high rates of comorbidity, and are associated with a four-fold increase in suicide risk. Research has established that tic symptoms and their change over time are highly idiographic. However, first-line, evidence-based, existing interventions are "one-size-fits-all," and are only effective for 60% of patients. The current study aims to use advanced statistical methods and a novel theoretical framework to map

Primary Outcome

ecological momentary assessment outcomes of tic change

Interventions

  • BEHAVIORAL Comprehensive Behavioral Intervention for Tics

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-03-31
Est. Completion 2029-05-15
Phase NA
University of Minnesota

966 total trials

What NCT06679790 shows while recruiting

NCT06679790 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 86-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (65% lower).

The record links to 2 conditions, with Tourette Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Comprehensive Behavioral Intervention for Tics is the first listed.

NCT06679790 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT06679790 about?

NCT06679790 is a clinical study titled "Trajectories of Change in Tourette Syndrome". This K23 Career Development Award is designed to provide the training needed for the PI to achieve her long-term career goal of conducting independent, programmatic intervention research in developmental populations. The training will emphasize gaining expertise in higher-intensity, multi-method, wi...

What is the current status of trial NCT06679790?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-03-31. Estimated completion is 2029-05-15.

What conditions does trial NCT06679790 study?

This clinical trial studies the following conditions: Tourette Syndrome, Tic Disorders.

What interventions are being tested in trial NCT06679790?

The interventions under investigation include: Comprehensive Behavioral Intervention for Tics (BEHAVIORAL).

Who is sponsoring clinical trial NCT06679790?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06679790 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tourette Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06679790's enrollment target sits among peer trials

30 24th of 33 higher than 10 of 33 other Tourette Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Tourette Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06679790, the US trial registry maintained by the National Library of Medicine. NCT06679790 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.